Single Cell Sequencing Market Size is Worth USD 3,230.6 Million by 2027 | CAGR of 13.9%: Emergen Research

Single Cell Sequencing Market Size is Worth USD 3,230.6 Million by 2027 | CAGR of 13.9%: Emergen Research

PR Newswire

VANCOUVER, BC, Sept. 28, 2020

- Growing usage of Single Cell sequencing in oncology is one of the significant factors influencing the market growth.

- Market Size – USD 1,136.1 Million in 2019, Market Growth - CAGR of 13.9%, Market Trends –Growing occurrence of chronic diseases

VANCOUVER, BC, Sept. 28, 2020 /PRNewswire/ -- The Global Single Cell Sequencing Market is expected to reach USD 3,230.6 Million by 2027, according to a new report by Emergen Research. Single Cell sequencing finds widespread use in resolving heterogeneity of tumor, reconstruction of cancer cell evolutionary courses, and identification of rare sub-clones, thereby providing a promising technique for addressing resistance to drugs. Recently, researchers at the University of South California (USC) developed a method using Single Cell sequencing to identify sub-clones in cancer tissue that could provide important biological insights into how cancer progresses, how it spreads, and why it can become resistant to treatment.


Increased investment in R&D activities by the companies in the Single Cell sequencing industry is crucial in driving the growth of the market. For instance, 10X Genomics, a leading biotech firm engaged in the design and production of tech for genome sequencing, reported that its R&D expenditures rose to USD 22.2 million in the third quarter 0f 2019 from USD 11.1 million in 2018 during the same period, fueled by increased funding in workforce hiring, infrastructure development, and supplies.

Request free sample of this research report at:

Key Highlights From The Report

To get leading market solutions, visit the link below:

Emergen Research has segmented the global Single Cell sequencing market on the basis of product type, workflow, technology, disease type, application, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2017-2027)

Workflow Outlook (Revenue, USD Billion; 2017-2027)

Technology Outlook (Revenue, USD Billion; 2017-2027)

Disease Type Outlook (Revenue, USD Billion; 2017-2027)

Application Outlook (Revenue, USD Billion; 2017-2027)

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Regional Outlook (Revenue, USD Billion; 2017-2027)

1.  U.S.

2.  Canada

1.  Germany

2.  U.K.

3.  France

4.  Benelux

5.  Rest of Europe

1.  China

2.  Japan

3.  South Korea

4.  Rest of APAC

1.  Brazil

2.  Rest of LATAM

1.  Saudi Arabia

2.  UAE

3.  Rest of MEA

Find more similar research insights by Emergen Research:

In-Vitro Diagnostics Market By Product (Reagents & Kits, Instruments), By Technique (Immunoassay, Clinical Chemistry), By Devices (Reusable IVD Devices, Disposable IVD Devices), By Application (Cancer, Infectious Diseases), By End-Use, and By Region, Forecasts to 2027

Cancer Immunotherapy Market By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors), By Application (Head & Neck Cancer, Blood Cancers, Liver Cancer), By End-Use (Cancer Specialty Centers, Hospitals and Clinics), and By Region, Forecasts to 2027

Blockchain in Healthcare Market By Type (Permissioned/Private Blockchain, Permissionless/Public Blockchain), By Application, By End-Users (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), Forecasts to 2027

Advanced Wound Care Market By Product Type (Moist Wound Dressing, Wound Therapy Devices), By Wound Type (Surgical Wounds, Ulcers, Burns, Traumatic Wounds), By End-User (Hospitals and Clinics, Home Care Settings), and By Region, Forecasts to 2027

Cancer Tumor Profiling Market By Technique Type (Genomics, Epigenetics, Metabolomics, Proteomics), By Technology (Immunoassays, In Situ Hybridization, PCR), By Application (Research And Clinical Application), Forecasts to 2027

Craniomaxillofacial Devices Market Analysis, By Product (Cranial Flap Fixation Device, CMF Distraction Device, Drugs), By Material (Metal Based Implants, Bioabsorbable Material), By Application, By End-Use, Forecasts to 2027

About Emergen Research 

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web:
Direct Line: +1 (604) 757-9756

Read full Press Release at : Cell-sequencing-market


Voltar noticias em Inglês